CONCLUSION
In summary, we identified that
CD15+LOX-1+ PMN-MDSC proportion
increases in PB of NSCLC patients, and combined detection of PMN-MDSCs
and traditional tumor markers can promote the diagnostic sensitivity and
specificity for NSCLC. Moreover,
CD15+LOX-1+ PMN-MDSCs are associated
with NSCLC prognosis and recurrence after surgery.